It lowers blood sugar while affecting protein and fat metabolism; inhibits liver glycogenolysis and gluconeogenesis, reducing liver output of glucose; promotes liver uptake of glucose and synthesis of liver glycogen; promotes muscle and adipose tissue uptake of glucose and amino acids, promotes protein and fat synthesis and storage; promotes the liver to produce very low density lipoprotein and activates lipoprotein lipase, promoting the decomposition of very low density lipoprotein; inhibits the decomposition of fat and protein in fat and muscle, inhibits the formation of ketone bodies and promotes the utilization of ketone bodies by surrounding tissues.

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Promote the liver to produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the production of ketone bodies and promote the use of ketone bodies by surrounding tissues.

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Promote the liver to produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the production of ketone bodies and promote the use of ketone bodies by surrounding tissues.

It is a fat-soluble quinone compound widely present in organisms. It plays an important role in proton translocation and electron transfer in the human respiratory chain. It can be used as an activator of cell metabolism and cell respiration. It is also an important antioxidant and nonspecific immunopotentiator. It has the effects of promoting oxidative phosphorylation and protecting the integrity of biological membrane structure. It has the effects of anti-myocardial ischemia, increasing cardiac output, reducing peripheral resistance, anti-heart failure, anti-arrhythmia, reducing peripheral vascular resistance, resisting the cardiotoxic effects of doxorubicin and protecting the liver. About 75% of patients with coronary heart disease can relieve symptoms such as angina pectoris, chest tightness, palpitations, and dyspnea after taking the drug, and the electrocardiogram can be improved. It is helpful in treating ventricular premature beats. In addition, it can be used as an adjuvant treatment for a variety of diseases.

This product belongs to the class of thiazolidinediones oral antidiabetic drugs, and is a highly selective peroxisome proliferator-activated receptor γ (PPARγ) agonist, which controls blood sugar levels by increasing peripheral and liver insulin sensitivity. Its main mechanism of action is to activate PPARγ nuclear receptors in tissues such as fat, skeletal muscle and liver where insulin acts, thereby regulating the transcription of insulin-responsive genes and controlling the generation, transport and utilization of blood sugar.

Aspartic acid is the precursor of oxaloacetate in the body and plays an important role in the tricarboxylic acid cycle. At the same time, aspartic acid also participates in the ornithine cycle, promoting the metabolism of ammonia and carbon dioxide, generating urea, and reducing the content of ammonia and carbon dioxide in the blood. Aspartic acid has a strong affinity with cells and can serve as a carrier for potassium and magnesium ions to enter cells, allowing potassium ions to return to cells, promoting cell depolarization and cell metabolism, and maintaining their normal functions.

Magnesium and potassium are important cations in cells and play an important role in various enzyme reactions and muscle contraction processes. The ratio of potassium ion, calcium ion, sodium ion and magnesium ion concentrations inside and outside cells affects myocardial contractility.

Magnesium and potassium are important cations in cells and play an important role in various enzyme reactions and muscle contraction. Magnesium ions are essential for the production of glycogen and high-energy phosphates.

It exerts antiplatelet and vasodilator effects by inhibiting the activity of phosphodiesterase in platelets and vascular smooth muscle, increasing the cAMP concentration in platelets and smooth muscle; inhibits the initial and secondary platelet aggregation and release reactions induced by ADP, adrenaline, collagen and arachidonic acid in a dose-related manner; does not interfere with the synthesis of vascular protective prostacyclin by vascular endothelial cells; for patients with chronic arterial occlusion, it can increase tissue blood flow in the foot and gastrocnemius muscles, increase the lower limb blood pressure index, increase skin blood flow and skin temperature of the limbs, and improve intermittent claudication.